Search research articles
Contact Us
Filters
Showing results (141-150 of 184) with videos related to
Page
of 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2009
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK
Alice T Shaw, Beow Y Yeap, Mari Mino-Kenudson, et al.
Cancer Medicine
|
March 21, 2022
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer
Benjamin Solomon, Ana Callejo, Jair Bar, et al.
The Oncologist
|
April 17, 2026
Characterization and Clinical Management of Adverse Events Following Treatment with Repotrectinib: A TRIDENT-1 Analysis
Alexander Drilon, Byoung Chul Cho, D Ross Camidge, et al.
The Oncologist
|
May 8, 2026
Characterization and clinical management of adverse events following treatment with repotrectinib: a TRIDENT-1 analysis
Alexander Drilon, Byoung Chul Cho, D Ross Camidge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 6, 2023
Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer
Trudy C Wu, Annalise Stube, Carol Felix, et al.
Targeted Oncology
|
October 24, 2023
A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Albiruni R Abdul Razak, Hung-Ming Wang, Jang-Yang Chang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 29, 2025
ETOP 25-23 ADOPT-lung: An international, multicentre, open-label randomised phase III trial to evaluate the benefit of adding adjuvant durvalumab after neoadjuvant chemotherapy plus durvalumab in patients with stage IIB-IIIB (N2) resectable NSCLC
Sabine Schmid, Georgia Dimopoulou, Paul van Schil, et al.
Clinical and Translational Radiation Oncology
|
March 11, 2026
Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy
Andrea R Filippi, Jair Bar, Daniel C Christoph, et al.
Nature Reviews. Clinical Oncology
|
March 24, 2021
Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Aakash Desai, Justin F Gainor, Aparna Hegde, et al.
Nature Reviews. Clinical Oncology
|
March 16, 2021
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Aakash Desai, Justin F Gainor, Aparna Hegde, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 184) with videos related to
Sort By:
Page
of 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 12, 2009
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK
Alice T Shaw, Beow Y Yeap, Mari Mino-Kenudson, et al.
Cancer Medicine
|
March 21, 2022
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer
Benjamin Solomon, Ana Callejo, Jair Bar, et al.
The Oncologist
|
April 17, 2026
Characterization and Clinical Management of Adverse Events Following Treatment with Repotrectinib: A TRIDENT-1 Analysis
Alexander Drilon, Byoung Chul Cho, D Ross Camidge, et al.
The Oncologist
|
May 8, 2026
Characterization and clinical management of adverse events following treatment with repotrectinib: a TRIDENT-1 analysis
Alexander Drilon, Byoung Chul Cho, D Ross Camidge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 6, 2023
Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer
Trudy C Wu, Annalise Stube, Carol Felix, et al.
Targeted Oncology
|
October 24, 2023
A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Albiruni R Abdul Razak, Hung-Ming Wang, Jang-Yang Chang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 29, 2025
ETOP 25-23 ADOPT-lung: An international, multicentre, open-label randomised phase III trial to evaluate the benefit of adding adjuvant durvalumab after neoadjuvant chemotherapy plus durvalumab in patients with stage IIB-IIIB (N2) resectable NSCLC
Sabine Schmid, Georgia Dimopoulou, Paul van Schil, et al.
Clinical and Translational Radiation Oncology
|
March 11, 2026
Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy
Andrea R Filippi, Jair Bar, Daniel C Christoph, et al.
Nature Reviews. Clinical Oncology
|
March 24, 2021
Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Aakash Desai, Justin F Gainor, Aparna Hegde, et al.
Nature Reviews. Clinical Oncology
|
March 16, 2021
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Aakash Desai, Justin F Gainor, Aparna Hegde, et al.
Page
of 19